Molecular Partners Ag (MOLN) EPS (Basic) (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly EPS (Basic) of -$0.0 for Q1 2026, up 17.82% year-on-year from -$0.0 in Q1 2025, and up 99.98% on a QoQ basis from -$2.2 in Q4 2025.
Molecular Partners Ag (MOLN) EPS (Basic) (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported EPS (Basic) for 7 consecutive years, with -$0.0 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) rose 17.82% year-over-year to -$0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 (down 20.11% YoY) and the FY2025 annual result came in at $2.7, down 43.24% from the prior year.
- EPS (Basic) advanced to -$0.0 in Q1 2026 per MOLN's latest filing, from -$2.2 in the prior quarter.
- Over the last five years, EPS (Basic) for MOLN reached as high as $3.93 in Q4 2022 and fell as low as -$2.2 in Q4 2023.
- A 5-year average of -$0.18 and a median of -$0.0 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) surged 830.17% — and 2023, when it slumped 274.91%.
- Year by year, EPS (Basic) stood at $3.93 in 2022, then plunged by 155.92% to -$2.2 in 2023, then climbed by 16.89% to -$1.83 in 2024, then fell by 20.13% to -$2.2 in 2025, then surged by 99.98% to -$0.0 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.0, -$2.2, and -$0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -2.20 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -1.83 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -2.20 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -0.54 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 3.93 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | -2.23 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -1.24 |